Clinical Trial Update: To Observe the CD7-targeted CAR-T Therapy in the Treatment of r/r PTCL [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is investigating a CD7-targeted CAR-T therapy for relapsed/refractory peripheral T-cell lymphoma and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Drugs mentioned

• CD7-targeted CAR-T therapy

Snippet

Sponsor: Peking University People's Hospital | Conditions: CD7 Positive R/R PTCL | Phase 1 | Status: RECRUITING